Literature DB >> 12559507

MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS?

G R Wayne Moore1.   

Abstract

Magnetic resonance imaging (MRI) is a sensitive technique in the detection and follow-up of multiple sclerosis (MS) lesions. However, the pathologic basis of these changes is poorly understood. It is becoming increasingly apparent that routine MRI techniques do not represent specific histopathologic changes but reflect a variety of pathological changes in tissue. This review will outline the findings in MRI-pathology correlation in MS to date, and the current understanding of the evolution of pathologic changes in the MS lesion and non-lesional white matter as reflected by MRI. Possible future contributions of MRI to unveiling the dynamic pathology of MS will also be discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12559507     DOI: 10.1016/s0022-510x(02)00347-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.

Authors:  Natalia M Moll; Anna M Rietsch; Smitha Thomas; Amy J Ransohoff; Jar-Chi Lee; Robert Fox; Ansi Chang; Richard M Ransohoff; Elizabeth Fisher
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

Review 2.  Magnetic resonance imaging of myelin.

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; David K B Li; Tony L Traboulsee; G R Wayne Moore; Alex L MacKay
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

3.  Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability.

Authors:  S Temel; H D Keklikoğlu; H D Kekliğkoğlu; G Vural; O Deniz; K Ercan
Journal:  Neuroradiol J       Date:  2013-03-08

4.  Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss.

Authors:  G R W Moore; C Laule; A Mackay; E Leung; D K B Li; G Zhao; A L Traboulsee; D W Paty
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

5.  Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain.

Authors:  Klaus Schmierer; Daniel J Tozer; Francesco Scaravilli; Daniel R Altmann; Gareth J Barker; Paul S Tofts; David H Miller
Journal:  J Magn Reson Imaging       Date:  2007-07       Impact factor: 4.813

6.  Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter.

Authors:  A Petzold; D J Tozer; K Schmierer
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

7.  Assessing brain injury topographically using MR neurite orientation dispersion and density imaging in multiple sclerosis.

Authors:  Amalie Chen; Sijin Wen; Dhairya A Lakhani; Si Gao; Keejin Yoon; Seth A Smith; Richard Dortch; Junzhong Xu; Francesca Bagnato
Journal:  J Neuroimaging       Date:  2021-05-25       Impact factor: 2.324

8.  Diffusion tensor imaging of post mortem multiple sclerosis brain.

Authors:  Klaus Schmierer; Claudia A M Wheeler-Kingshott; Phil A Boulby; Francesco Scaravilli; Daniel R Altmann; Gareth J Barker; Paul S Tofts; David H Miller
Journal:  Neuroimage       Date:  2006-12-16       Impact factor: 6.556

9.  Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple Sclerosis.

Authors:  Keejin Yoon; Derek B Archer; Margareta A Clarke; Seth A Smith; Ipek Oguz; Gary Cutter; Junzhong Xu; Francesca Bagnato
Journal:  Front Neurol       Date:  2022-06-15       Impact factor: 4.086

10.  Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation.

Authors:  Klaus Schmierer; Claudia A M Wheeler-Kingshott; Daniel J Tozer; Phil A Boulby; Harold G Parkes; Tarek A Yousry; Francesco Scaravilli; Gareth J Barker; Paul S Tofts; David H Miller
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.